Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for ELOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2025 -6.327M
December 31, 2022 -31.84M
December 31, 2021 -35.00M
December 31, 2020 -28.17M
December 31, 2019 -39.39M
December 31, 2018 -31.37M
December 31, 2017 -15.94M
June 30, 2016 -3.676M
June 30, 2015 -7.345M
June 30, 2014 -4.868M
June 30, 2013 -3.903M
June 30, 2012 -4.386M
June 30, 2011 -5.391M
Date Value
June 30, 2010 -4.743M
June 30, 2009 -3.963M
June 30, 2008 -2.405M
June 30, 2007 -2.032M
June 30, 2006 -2.530M
June 30, 2005 -2.116M
June 30, 2004 -1.893M
June 30, 2003 -2.002M
June 30, 2002 -1.313M
June 30, 2001 -1.484M
June 30, 2000 -1.865M
June 30, 1999 -0.9738M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Filana Therapeutics, Inc. -32.25M
CorMedix, Inc. 175.05M
Cannabis Global, Inc. -0.2899M
Breakthrough Chemistry, Inc. -0.0131M
BioStem Technologies, Inc. 9.941M